We’ve compiled the most relevant results based on your search. Please review the listings below to find what best meets your needs.
If you don’t see what you’re looking for, consider refining your search or adjusting the filters or using the form below to contact us.
Early exposure to opioids in the home significantly increases the risk of later opioid use disorder. This article highlights key adolescent risk factors—parental practices, health beliefs, and early alcohol use—and stresses the importance of prevention through safe storage, disposal, and early interventions at both family and school levels.
A national study of over 3,000 U.S. secondary school students found a strong link between high medical and nonmedical use of ADHD stimulants. Certain school and demographic factors increased risk. The findings highlight the need for targeted prevention efforts in schools with high stimulant prescription rates to reduce misuse.
DEA testing shows a sharp rise in the danger of counterfeit pills, with 60% now containing a potentially lethal dose of fentanyl—up from 40% in 2021. Often made by Mexican cartels to mimic real prescription opioids, these pills pose serious risks, reinforcing warnings against using non-prescribed medications.
This national report highlights 2014 behavioral health data, revealing increases in marijuana and heroin use, while nonmedical pain reliever use declined. Substance use disorders affected 21.5 million Americans, with alcohol use disorder being most common. Mental illness remained prevalent, especially among young adults. The findings underscore prevention and treatment priorities.
Two-thirds of U.S. adults use prescription drugs, with older adults and those with chronic conditions accounting for most usage. Rising medication use and technological advances have driven up costs, sometimes leading patients to underuse prescriptions. This article examines the role of demographics, chronic illness, and policy in medication compliance.
Pharmacies are often the most accessible health care provider for millions of Americans, with most Americans living within five miles of a pharmacy.
This guide outlines best practices for safely disposing of unwanted pharmaceuticals during and after emergencies. It covers disposal methods like incineration and landfill burial, categorization, handling, and stakeholder coordination. Designed for healthcare providers, NGOs, and governments, it aims to reduce environmental harm and prevent misuse during crisis response efforts.
This article explores cost-effective methods for treating and disposing of regulated medical waste (RMW), based on findings from three Massachusetts hospitals. It highlights proper waste sorting and the combined use of on-site incineration and microwaving. The study also recommends standardized classification into four categories to improve efficiency and cost savings.
This study examines the economic cost of opioid use disorder (OUD) and the societal value of preventing it. Using 2015–2018 data, it analyzes the financial burden across taxpayers, healthcare, and society, revealing increased spending despite a decline in OUD cases—largely due to the rising prevalence of fentanyl.
The majority of Americans are not aware of safe medication disposal practices and tend to keep unused medications to avoid doctor visits and to save money. Common practices include throwing pharmaceuticals in the trash and flushing them. The article highlights safe disposal practices and emphasizes the need to implement them as a way to avoid societal harm.